Indegene (INDGN.NS) Stock Price
Indegene Price
Revenue has compounded at 32.7% per year over the past 6 years to 35.11 B INR. Earnings per share have grown at 38.9% per year over the last 6 years. Indegene's net margin stands at 11.4%, up from 9.9% several years earlier. Indegene currently offers a dividend yield of about 0.34%. The payout ratio is around 12% of earnings. Analysts set a median price target of 612.00 INR, implying 5.5% above the current price. Of 14 analysts, 10 rate the stock a buy — an overall Buy consensus.
Indegene stock price
Indegene business model & stock analysis
Frequently asked questions about Indegene
Analysts currently set an average price target of 614.24 INR for the Indegene stock (median: 612.00 INR), implying +5.9 % versus the latest price. The consensus is based on 14 analyst ratings.
14 analysts currently rate the Indegene stock: 10 recommend buying, 4 holding and 0 selling.
Converted at the current exchange rate, the Indegene share trades at 5.35 EUR (580.10 INR).
The revenue of Indegene is 35.11 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Indegene is 4.01 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Indegene is currently 34.94. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Indegene stock.
The price-to-sales ratio (P/S) of Indegene is currently 3.99. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Indegene stock.
The Eulerpool Quality Score for Indegene is 5/10.
The ISIN of Indegene is INE065X01017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Indegene is INDGN.NS. The ticker symbol is used to trade Indegene shares on the stock exchange.
Indegene stock
Indegene Peer Group
All fundamentals and in-depth analysis of Indegene
Our stock analysis for Indegene stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Indegene. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.